Riktlinjer från Svensk Gastroenterologisk Förening.
Introduktion till IBS, symtom, diagnostik och behandling.
Artikeln publicerad under fliken "Riktlinjer" på föreningens hemsida:
svenskgastroenterologi.se   

Törnblom H.
IBS - utredning och behandling.
Distriktsläkaren 2010; No 6, 19-24.

Quigley E M M, Keohane J.
Dyspepsia.
Current Opinion in Gastroenterology 2008; 24(6): 692-697.

1. Wagner H, Allescher HD.
Editorial.
Phytomedicine 2006, 13, 1.

2. Allescher HD.
Functional dyspepsia - A multicausal disease and its therapy.
Phytomedicine 2006, 13, 2-11.

3. Kroll U, Cordes C.
Pharmaceutical prerequisites for a multi-target therapy.
Phytomedicine 2006, 13, 12-19.

4. Wegener T, Wagner H.
The active components and the pharmacological multi-target principle of STW 5 (Iberogast).
Phytomedicine 2006, 13, 20-35.

5. Schempp H, Weiser D, Kelber O, Elstner EF.
Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components.
Phytomedicine 2006, 13, 36-44.

6. Germann I, Hagelauer D, Kelber O, Vinson B, Laufer S, Weiser D, Heinle H.
Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast).
Phytomedicine 2006, 13, 45-50.

7. Simmen U, Kelber O, Okpanyi SN, Jaeggi R, Bueter B, Weiser D.
Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarine M3,
and opioid receptors.
Phytomedicine 2006,13, 51-55.

8. Khayyal MT, Seif-El-Nasr M, El-Ghazaly MA, Okpanyi SN, Kelber O, Weiser D.
Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity.
Phytomedicine 2006, 13, 56-66.

9. Ammon HPT, Kelber O, Okpanyi SN.
Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.
Phytomedicine 2006, 13, 67-74.

10. Heinle H, Hagelaur D, Pascht U, Kelber O, Weiser D.
Intestinal spasmolytic effects of STW 5 (Iberogast) and its components.
Phytomedicine 2006, 13, 75-79.

11. Sibaev A, Yuece B, Kelber O, Weiser D, Schirra J, Göke B, Allescher HD, Storr M.
STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.
Phytomedicine 2006, 13, 80-89.

12. Schermann M, Michel K, Zeller F, Hohenester B, Rühl A.
Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
Phytomedicine 2006, 13, 90-99.

13. Müller MH, Liu CY, Glatzle J, Weiser D, Kelber O, Enck P, Grundy D, Kreis ME.
STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
Phytomedicine 2006, 13, 00-106.

14. Kelber O, Wittwer A, Lapke C, kroll U, Weiser D, Okpanyi SN, Heilmann J.
Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components.
Phytomedicine 2006, 13, 107-113.

15. Rösch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G.
Phytotherapy for functional dyspepsia: A review of the clinical evidence for the herbal preparation STW 5.
Phytomedicine 2006, 13, 114-121.

16. Wagner H.
Multitarget therapy - The future of treatment for more than just functional dyspepsia.
Phytomedicine 2006, 13, 122-129.

1. Lee KJ et al.
Pathophysiology of functional dyspepsia.
Best Pract Res Clin Gastroenterol 2004; 18: 707-716.

2. Drossman DA et al.
US housholder survey of functional gastrointestinal disorders.
Prevalence, sociodemography and health impact.
Dig Dis Sci 1993; 38: 1569-1580.

3. Ahn J, Ehrenpreis ED.
Emerging treatments for irritable bowel syndrome.
Expert opin Pharmacother 2001; 3: 9-21.

4. Ford AC et al.
Clin Gastroenterol Hepatol 2010; 8: 401-409.

5. Moayyedi P et al.
Gastroenterology 2004; 127: 1329-1337.

6. Reimer C et al.
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal Therapy.
Gastroenterology 2009; 137: 80-87.

7. Moayyedi P et al.
Cohrane Database Syst Rev 2005; 1: CD002096, Update 2006; 2: CD00296.

9. Symposium on "Functional GI Diseases: Solving the Therapeutic Dilemma", held
as part of the "European Bridging Meeting in Gastroenterology", on 18th November 2010 in Berlin.
Bilaga till Zeitschrift für Gastroenterologie 49. Jahrgang, Heft 2, Februar 2011.

10. Ohlsson B, Truedsson M.
Tarmkanalens funktionsrubbningar.
Läkemedelsboken 2009-2010, kapitel 21. Apoteket AB.

11. Törnblom H.
IBS - utredning och behandling.
Distriktsläkaren 2010; 6: 19-24.
​